Gulf Today Report
Indian shares slumped on Thursday as UPL, agrochemical firm slid by 15% and Nifty recorded seven sessions of gains.
The NSE Nifty 50 index fell 0.91% to 13,405.65 by 0439 GMT, while the benchmark S&P BSE Sensex was down 0.81% at 45,729.27. The indexes had hit record highs in 14 of the previous 21 sessions, driven mainly by news of progress in coronavirus vaccines.
READ MORE
Oil jumps on COVID-19 vaccine roll-out and approval
Gold steadies as investors await stimulus
Tesco''s Asia deal paves way for $6.7 billion shareholder windfall
India is working on approving vaccine but the authorities said it will need more data before deciding on AstraZeneca and Bharat Biotech vaccines.
UPL had the highest lost due to a whistleblowing report.
"Markets will digest all negative news now, the second half of December could be more tricky than most people thought. I would be very circumspect about markets going up from here,” said Securities Director Sanjiv Bhasin.